$MATN Mateon Therapeutics (OTCQB: MATN) to Develop its OT-101, a Phase 3 Clinical Drug Candidate, Initially Against COVID-19

https://t.co/wlfsBg90y4

$CYDY $AZN $BBIO $PFE $RHHBY $CANF $EPIX $MRK $GNCA $SYBX 

#CoronaVirus #Covid19  #HotStocks #StockMarket #Daytrade #Profit